MAPT and Alzheimer disease: Amyloid deposition and tau protein fibrillary tangles, which are the hallmark neuropathological markers of the illness, as well as the AD risk gene (Apo E), cause mitochondrial abnormalities, which lead to pathology alterations and possibly mitochondrial metabolic malfunction (Figure 1) [11].